Infertility Clinical Trial
Official title:
Follow-up of Children Born From Freeze-only Versus Fresh Embryo Transfer: a Follow-up of a Randomized Controlled Trial
In order to give strong recommendation on the efficacy and safety of fresh versus frozen embryo transfer, we conduct this study in order to investigate the physical and mental development of children from fresh versus frozen embryo transfer. Based on our Freeze-only study (Vuong et al., 2018), the women without polycystic ovary syndrome undergoing the first or second IVF were randomly assigned to receive either fresh or frozen embryos on day 3 after oocyte retrieval, which leads to the similarity in characteristics of these two groups. Hence, the result from analysing these offsprings would be preciously valuable.
Since the first live birth after the transfer of a frozen-thawed embryo reported in 1984,
cryopreservation has been considered as an enormous revolution in assisted reproductive
technology (ART). It is observed that the trend of ART cycles using frozen embryo transfer is
on the increase, which leads to a great deal number of children born from frozen embryos.
This is the commencement of 2 embryo transfer strategies, the first one is transferring the
fresh embryos, the other is freezing all the embryos and transfer them in the next cycle.
Comparing these two strategies, up till now, there are 4 published randomized control trials
(RCTs) indicating different methods for certain groups of patients (Chen et al., 2016; Shi et
al., 2018; Vuong et al., 2018; Wei et al., 2019). Regarding the efficacy, the freeze-all
strategy outweighs the fresh embryo transfer in women with polycystic ovary syndrome (PCOS).
While that efficacy gets a controversy in non-PCOS or ovulatory patients; two groups of
authors indicated that these 2 strategies are equally effective, while the other group claims
that the better result goes to cycles with frozen embryos. In term of safety, the rate of
ovarian hyperstimulation syndrome (OHSS) is the equivalent or lower in the freeze-all group,
which implies the important role of embryo-freezing in avoiding maternal risk. The question
that whether freezing the embryos exerts effect on offspring is not thoroughly understood.
The mostly used parameter in evaluating the safety of children is the perinatal status of
infants, not the development of these children.
Searching literature, in 2010, S. Pelkonen published a large cohort study indicating that
freezing the embryos do not change the rate of prematurity, low birthweight and being small
for gestational age (Pelkonen et al., 2010). Looking further in our freeze-only study, our
sub-analysis indicates that the livebirth weight of infants born from frozen embryos is 300
gram heavier than that from fresh embryos (Vuong et al., 2018). Following 4 studies comparing
fresh and frozen embryo transfer, children from frozen embryos are similar or higher in term
of newborn weight, and there is no study investigate the onward development of childrens born
from these two strategies. The only proof on the development of children born from fresh
verus frozen embryo is from one study with no randomization which states that children from
fresh and frozen embryos share similar academic performance at the age 15-16 (Spangmose et
al., 2019). We found no study investigate the impact of different embryo transfer strategies
on the growth of children resulting from either fresh or frozen embryos.
In order to give strong recommendation on the efficacy and safety of fresh versus frozen
embryo transfer, we conduct this study in order to investigate the physical and mental
development of children from fresh versus frozen embryo transfer. Based on our Freeze-only
study (Vuong et al., 2018), the women without polycystic ovary syndrome undergoing the first
or second IVF were randomly assigned to receive either fresh or frozen embryos on day 3 after
oocyte retrieval, which leads to the similarity in characteristics of these two groups.
Hence, the result from analysing these offsprings would be preciously valuable.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A |